A return to normalcy requires us to address the limits of current testing approaches and broadly deploy reliable screening tools that facilitate early detection and encourage more focused testing of those at high-risk of spreading the coronavirus.
Although the cloud offers great value for medtech manufacturers and device users, it also creates new challenges.
Understanding the GMP requirements of each component is critical to product and compliance success.
It’s time to consider CAPAs as opportunities rather than just other issues to tackle.
The challenge for the digital health community will be to bring the same high standards for care in the physical world to their digital interactions.
A review of new, successful treatment options for the novel coronavirus.
The technology behind remote cardiac device monitoring is becoming more convenient, responsive and connected across the digital ecosystem—including a new smartphone app.
The absence of any of these disciplines can lead to blind spots that can introduce risk, but they are not all created equal.
No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
Moving too quickly in the product development process can lead to mistakes.